For RFS, the vascular invasion (P < 0.001), tumor TNM staging (P < 0.001), Serum AFP level (P = 0.029), and high expression of CTSA mRNA (P = 0.003) were risk factors. This evidence concerns the gene CTSA and neoplasm.